Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Compound 4 is a promising treatment for hair loss with low toxicity.

mTOR may link different pathways in hair follicle tumor formation.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

New mouse models help study melanocytic cells for melanoma research.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

The method effectively induces skin cancer in mice for studying tumor development.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Reduced Sonic hedgehog signaling leads to increased HPV replication and wart formation.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.